Nurix Stock Market Sentiment

NRIX
 Stock
  

USD 13.03  0.14  1.09%   

Nurix investor sentiment overview provides quick insight into current market opportunities from investing in Nurix Therapeutics. The current market sentiment together Nurix Therapeutics' historical and current headlines can help investors to time the market. Many technical investors use Nurix Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Additionally, see Nurix Therapeutics Hype Analysis, Nurix Therapeutics Correlation and Nurix Therapeutics Performance.
  
Nurix Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nurix daily returns and investor perception about the current pice of Nurix Therapeutics as well as its diversification or hedging effects on your existing portfolios.

Nurix Therapeutics Sentiment by Major News Outlets

over a week ago at finance.yahoo.com         
40 Key Companies Actively Working in the Marginal Zone Lymphoma Pipeline Segment DelveInsight - Yaho...
Yahoo News
over two weeks ago at www.macroaxis.com         
Acquisition by Saltzman Edward C of 50000 shares of Nurix Therapeutics subject to Rule 16b-3
Macroaxis News
over a month ago at www.marketbeat.com         
Nurix Therapeutics, Inc. Given Average Rating of Buy by Analysts - MarketBeat
Marketbeat News
over a month ago at www.macroaxis.com         
Acquisition by Van Houte Hans of 120000 shares of Nurix Therapeutics subject to Rule 16b-3
Macroaxis News
over a month ago at www.marketbeat.com         
Nurix Therapeutics, Inc. Given Average Recommendation of Buy by Analysts - MarketBeat
Marketbeat News
over two months ago at www.macroaxis.com         
Exercise or conversion by Van Houte Hans of 2886 shares of Nurix Therapeutics subject to Rule 16b-3
Macroaxis News
over two months ago at www.defenseworld.net         
Nurix Therapeutics Shares Down 2 percent - Defense World
news
over two months ago at seekingalpha.com         
Nurix Therapeutics, Inc. Stock Price Today, Quote News - Seeking Alpha
seekingalpha News
over two months ago at www.marketscreener.com         
Needham Adjusts Nurix Therapeutics Price Target to 32 from 38, Keeps Buy Rating - Marketscreener.com
Macroaxis News: marketscreener.com
over two months ago at www.bioworld.com         
Financings for July 11, 2022 - BioWorld Online
news
over two months ago at www.benzinga.com         
The Daily Biotech Pulse Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio Ridgeback To I...
benzinga news
over two months ago at www.globenewswire.com         
Nurix Therapeutics Announces 55 Million Registered Direct Offering - GlobeNewswire
Macroaxis News: globenewswire.com
over two months ago at uk.yahoo.com         
Shareholders in Nurix Therapeutics are in the red if they invested a year ago - Yahoo Movies UK
Yahoo News
over three months ago at Macroaxis         
Chances of Nurix Therapeutics to slide after the volatility rises
Macroaxis News
over three months ago at seekingalpha.com         
FDA approves expansion of Nurix Therapeutics phase 1 trial of NX-1607 into the U.S. - Seeking Alpha
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Nurix Therapeutics that are available to investors today. That information is available publicly through Nurix media outlets and privately through word of mouth or via Nurix internal channels. However, regardless of the origin, that massive amount of Nurix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nurix Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nurix Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nurix Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nurix Therapeutics alpha.

Nurix Therapeutics Performance against DOW

 Price Growth (%)  
       Timeline  
1
Financings for July 11, 2022 - BioWorld Online07/11/2022
2
Nurix Therapeutics Shares Down 2 percent - Defense World07/20/2022
3
Exercise or conversion by Van Houte Hans of 2886 shares of N...08/02/2022
4
Acquisition by Van Houte Hans of 120000 shares of Nurix Ther...08/10/2022
5
Acquisition by Saltzman Edward C of 50000 shares of Nurix Th...09/14/2022
6
40 Key Companies Actively Working in the Marginal Zone Lymph...09/21/2022
Additionally, see Nurix Therapeutics Hype Analysis, Nurix Therapeutics Correlation and Nurix Therapeutics Performance. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for analysis

When running Nurix Therapeutics price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Is Nurix Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix Therapeutics. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nurix Therapeutics is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Nurix Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix Therapeutics' market value can be influenced by many factors that don't directly affect Nurix Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Nurix Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.